UK Chemotherapy Board

Pinkie is currently undertaking a PhD at University College London funded through the NIHR academy. Her research aims to determine the optimal blood testing validity periods for chemotherapy patients using risk modelling techniques. Her substantive role at UCLH is Lead Pharmacist for Applied Health research, a role that focuses on translational type 2 research. She has held various roles within cancer including developing new clinic pharmacy services at UCLH and Lead Pharmacist for London Cancer. She is a member of the UK Chemotherapy board as a BOPA representative , Joint Chair of The Chemotherapy Expert Reference group in London Cancer and a member of the Heath Foundation Q Community.

Netty is an experienced oncology pharmacist and has worked for over 15 years in this sector. She has a vast range of experience including lead oncology and haemato-oncology pharmacist within an NHS Trust, a lead role within an NHS cancer network, and project management roles for the implementation of SACT electronic prescribing both in the NHS and the independent sector. She is currently the Lead Cancer Pharmacist for Ramsay Healthcare UK. During these 15 years Netty has been an active member of BOPA and her current role within the executive committee is the BOPA secretary and Co-Chair of the Digital Subcommittee.

Netty also chairs the Independent Sector Oncology Pharmacy Group and is a member of the Independent Sector Cancer Network and UK Chemotherapy Forum where she represents BOPA. She is passionate about improving cancer care within the independent sector and improving safety for patients and staff with the use of digital media.